Search by Drug Name or NDC
NDC 00409-0830-01 Aztreonam 2 g/1 Details
Aztreonam 2 g/1
Aztreonam is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is AZTREONAM.
MedlinePlus Drug Summary
Aztreonam injection is used to treat certain infections that are caused by bacteria, including respiratory tract (including pneumonia and bronchitis), urinary tract, blood, skin, gynecological, and abdominal (stomach area) infections, that are caused by bacteria. Aztreonam injection also may be used before, during, and sometimes for a brief period after surgery in order to prevent the patient from getting an infection. It is also used for the prevention of infections following colorectal surgery. Aztreonam is in a class of medications called monobactam antibiotics. It works by killing bacteria. Antibiotics such as aztreonam injection will not work for colds, flu, or other viral infections. Taking antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 00409-0830-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Aztreonam Injection
Product Information
| NDC | 00409-0830 |
|---|---|
| Product ID | 0409-0830_cbefea63-fdf4-45f7-9dae-3059a0394feb |
| Associated GPIs | 16140010002130 |
| GCN Sequence Number | 009362 |
| GCN Sequence Number Description | aztreonam VIAL 2 G INJECTION |
| HIC3 | W1P |
| HIC3 Description | BETALACTAMS |
| GCN | 41912 |
| HICL Sequence Number | 004053 |
| HICL Sequence Number Description | AZTREONAM |
| Brand/Generic | Generic |
| Proprietary Name | Aztreonam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Aztreonam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | g/1 |
| Substance Name | AZTREONAM |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Monobactam Antibacterial [EPC], Monobactams [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206517 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00409-0830-01 (00409083001)
| NDC Package Code | 0409-0830-01 |
|---|---|
| Billing NDC | 00409083001 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-0830-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-0830-11) |
| Marketing Start Date | 2022-01-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |